CD4+Th I as the prevalent lymphocyte subset (8) (9) , perhaps responsible for autoimmune melanocyte destruction (10) . Hashimoto's thyroiditis is also characterized by a prevalent Th I-driven autoimmune process, as observed by measuring cytokines in PBL by flow cytometric analysis (11). An elevated CD4+1 CD8+ ratio in PBL was reported when vitiligo and other autoimmune diseases were simultaneously present (8) . However, it is not known whether Th subsets of lymphocytes may be modified when vitiligo is associated with HT. This study is aimed at analyzing selected intracellular cytokines (Th I: IL-2 and IFN-y; Th2: IL-4) in patients with HT isolated or associated with non-segmental vitiligo.
MATERIALS AND METHODS

Patients
We selected 23 Caucasian patients (20W13M; median age=31 yrs) with isolated euthyroid HT (group A) and II patients (5W/6M; median age=40 yrs) with euthyroid HT associated with non-segmental vitiligo (group B). The inclusion criterion was a definite diagnosis ofHashimoto 's thyroiditis in all patients. The diagnosis of Hashimoto's thyroiditis was based on peculiar ultrasonographic pattern (13) , presence of antiperoxidase antibodies and, when present, mild or overt hypothyroidism. In this latter case, prior to the study, patients were treated with levothyroxine in replacement modality to achieve euthyroidism, The diagnosis of non-segmental vitiligo in the patients ofgroup B was based on the criteria described previously (3) . The diagnosis was made on clinical grounds. Exclusion criteria were: a) the presence of anti-TSH receptor antibodies or ultrasonographic evidence of thyroid atrophy; b) clinical history of hyperthyroidism; c) evidence of infectious diseases in the last three months; d) treatment with drugs known to interfere with the immune system, namely cytokines, interferon, corticosteroids, NSAIDs, amiodarone, lithium; e) pregnancy and lactation over the previous 6 months; t) presence ofacute or chronic systemic diseases other than vitiligo. Written informed consent was signed by all patients and the protocol of this study was consistent with the declaration of Helsinki.
Methods
Blood samples were collected from all patients and immediately processed. Peripheral blood lymphocytes (PBL) were separated using Ficoll Hypaque density gradient centrifugation. PBL were washed twice and resuspended in RPMI-1640 supplemented with 10% FCS. The cell suspension was cultured in 24 well plates at 37°C and 5% CO for 24 hours. Surface staining of PBL was performed~sing FITC-conjugated MoAb (anti-CD4, anti-CD8).
Intracellular cytokine study
During the last 18 hours of incubation, cells were stimulated with PMA (16 nM), ionomycin (lIlM) and monensin (20 IlM) and were collected, washed in PBS and then fixed with paraformaldehyde (PFA) 2% for 20 min at room temperature (14) . The cell suspension was permeabilized with digitonin (60 IlM) in the presence of specific monoclonal antibodies FITC-conjugated (anti-IL-2, anti-IL-4, anti IFN-y) and isotype-matched antibody. All samples were resuspended in PBS for flow cytometric analysis (14) .
Flow cytometric analysis
Fluorescence of each sample was analyzed at 488 nm on an EPICS XL Flow cytometer (Coulter, Hialeah, FL) equipped with an argon laser. PBL were gated on the basis of forward angle light scatter (FS) and 90°light scatter parameters (SS), the percentage of purity was analyzed using MoAb anti-CD2.
Hormonal assays
FT4 levels were assayed by commercial radioimmunoassay (normal range= 10-23 pmol/l). TSH levels were assayed by immunoradiometric assay (normal range= 0.2-4 mUll). The anti-peroxidase auto antibodies (anti-TPOAb) were measured by a radioligand assay (intra-assay variation 3.6% inter-assay, variation 4.6%; Radim Techland, Liege, Belgium). Anti-TPOAb titers stably >200 U/mL in at least 2 separate measurements have been considered consistent with the presence of autoimmune thyroiditis (mean serum concentrations: control patients =1354±2489 U/mL; patients with HT and vitiligo =2060±3071 U/mL)
Statistical analysis
Data are expressed as median values (Interquartile range, IQ 
RESULTS
Surface analysis showed similar lymphocyte subpopulations in the two groups of patients, except for a slight but significant reduction of CD4+ICD8+ (Table I) . This was due to the combined effect of an increase of CD8+ lymphocytes and a decrease of CD4+ lymphocytes which were, however, not significant (p=0.506 and p=0.25I , respectively). When intracellular cytokines (Th I) were analyzed, the percentage ofIL-2+cells was above the reference range in all patients enrolled in the study, but the median value of positive cells was similar in the two groups (A=34.4%, IQI-1Q3 27.6-43.6 % vs B=32.8%, IQI-1Q3 22.7-40.2 %; p=ns) ( Fig.  la) . Even the percentage of IFN-y positive cells was mildly increased in all patients with isolated HT and in those with concurrent vitiligo without significant differences (A=19.0%, IQI-1Q3 14.0-23.8 % vs B=14.8%, IQI-1Q3 12.5-30.3 %; p=ns) ( Fig.  1b) . As far as IL-4, a representative Th2 cytokine, is concerned, the number of positive cells was in the normal range in most patients with isolated HT (21/23) ( Fig. 2a) and clearly above the range in those with HT and vitiligo (9/11); (p<0.0001; RR= 9.409) (Fig. 2b) . The resulting median number of IL-4 positive cells of these two groups is shown in Fig. 3 . No correlations were observed between age and/or anti-thyroperoxidase antibody levels (Spearman's correlation test; p= ns for all variables). Similarly, the percentage of IL-4 positive lymphocytes was independent from sex and and did not correlate with any CD lymphocyte subpopulations (not shown).
Finally, the IFN-y/IL-4 ratio, used as a measure of Thl/Th2 balance, was significantly different in patients with isolated HT (3.70) than in patients with vitiligo associated with HT (0.80; p= 0.0022).
DISCUSSION
Chronic thyroiditis and non-segmental vitiligo may co-exist in the same patients but to date very few data are available about surface lymphocytic antigen distribution and a possible cytokine profile adjustment in these associated disorders. Data obtained analyzing the surface antigens in peripheral blood lymphocytes of patients with isolated vitiligo were scarce and inconclusive (5) . In fact, increased CD4+ lymphocytes and high CD4+/CD8+ ratio were found in patients with stable vitiligo and in their first degree relatives (15) , while a prevalent CD8+ differentiation in perilesional skin from patients with isolated vitiligo has been reported (10) . In an early study, the presence of autoimmune and/or additional endocrine diseases in patients with vitiligo did not affect lymphocyte subpopulation distribution (16) . Recently, however, CD4+ T cell prevalence has been described in vitiligo, both isolated and/or associated with different autoimmune diseases (8) . In the present study, a reduction of CD4+ and a small increase of CD8+ led to a CD4+/CD8+ ratio in patients with HT and vitiligo lower than that observed in isolated HT. 
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However, due to the small differences observed, studies in greater samples should be carried out to draw definite conclusions on this issue. A prevalent Th l-driven autoimmune response has been clearly recognized in Hashimoto's thyroiditis (11), while previous studies dealing with cytokine expression in patients with vitiligo showed an increased production of proinflammatory cytokines such as IL-l~, IL-6, IL-8, and TNF-u (9, 17) . Tissue levels of IL-4 were similar in healthy subjects and in patients with vitiligo while higher but progressively decreasing IL-IO levels were described in vitiligo patients (9, 18) . A clear-cut Th 1 polarization has been reported by Wankowicz-Kalinska et at. (l0) in vitiligo perilesional skin, with simultaneous downregulation ofTh2 cytokines. In a recent report, serum TGF-~levels were significantly decreased in all clinical presentations of vitiligo compared to control subjects (9) . TGF-~plays a key role in favouring T regulatory cell (Treg) activity and survival (18) (19) and, thus, its reduction in vitiligo may affect the balance between proinflammatory and regulatory T cells. Interestingly, higher serum TGF-~levels were observed in patients with vitiligo and associated autoimmune diseases compared with the patients without concomitant autoimmune disorders (9) . 
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Some authors have suggested that the higher TGFlevels might be more related to these associated diseases than to the vitiligo itself, also implying that cytokine profile may differ when autoimmune disorders occur in isolated or associated form (9) . This finding is somewhat similar to that observed in our study: IL-4+ PBL median values were in the normal range in patients with isolated HT and clearly enhanced in those showing HT associated with nonsegmental vitiligo. However, in our patients, the decrease of Th 1 cytokines (IFN-y and IL-2), which was expected when Th2 profile is enhanced (20) , was small and not statistically significant. This evidence shows a less polarized Th l/Th2 balance in patients with HT and concomitant vitiligo. It has been reported that a Th 1 cytokine profile may be the prevalent one in patients with organ-specific autoimmunity, whereas a prevalent Th2 profile has been associated with systemic autoimmunity (20) . On this basis, it has been postulated that when Th 1 immune response becomes severe and involves more than one organ and/or system, there is a shift towards a more protective cytokine subset (Th2) leading to antiapoptotic events (20) . In accordance with this hypothesis is the pharmacologic attempt (e.g. tacrolimus) to suppress Thl and enhance Th2 response in patients with vitiligo (21) .
In conclusion, an increased number of interleukin-4 positive lymphocytes was observed in patients with Hashimoto's thyroiditis associated with non-segmental vitiligo, suggesting a modified balance from highly prevalent Thl to mixed Thl/ Th2 subset. This may represent a more general adaptive phenomenon when the association of more Th l-driven autoimmune diseases needs to be immunologically counterbalanced and further supports the autoimmune pathogenesis of the "non-segmental vitiligo. Further studies on larger samples and evaluating tissue cytokines in addition to peripheral blood will help to clarify the changing features of adaptive immunity in these associated disorders.
